A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder

Conditions: Autism Spectrum Disorder Interventions: Drug: Low Dose ARD-501; Drug: High Dose ARD-501; Drug: Placebo Sponsors: Aardvark Therapeutics, Inc.; Center for Psychiatry And Behavioral Medicine Inc. Not yet recruiting

https://clinicaltrials.gov/study/NCT06126653

Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials

More News: Autism | Psychiatry | Research | Study